L-Serine dietary supplementation is associated with clinical improvement of loss-of-function GRIN2B-related pediatric encephalopathy


Por: Soto, D, Olivella, M, Grau, C, Armstrong, J, Alcon, C, Gasull, X, Santos-Gomez, A, Locubiche, S, de Salazar, MG, Garcia-Diaz, R, Gratacos-Batlle, E, Ramos-Vicente, D, Chu-Van, E, Colsch, B, Fernandez-Duenas, V, Ciruela, F, Bayes, A, Sindreu, C, Lopez-Sala, A, Garcia-Cazorla, A, Altafaj, X

Publicada: 18 jun 2019
Resumen:
Autosomal dominant mutations in GRIN2B are associated with severe encephalopathy, but little is known about the pathophysiological outcomes and any potential therapeutic interventions. Genetic studies have described the association between de novo mutations of genes encoding the subunits of the N-methyl-D-aspartate receptor (NMDAR) and severe neurological conditions. Here, we evaluated a missense mutation in GRIN2B, causing a proline-to-threonine switch (P553T) in the GIuN2B subunit of NMDAR, which was found in a 5-year-old patient with Rett-like syndrome with severe encephalopathy. Structural molecular modeling predicted a reduced pore size of the mutant GIuN2B-containing NMDAR5. Electrophysiological recordings in a HEK-293T cell line expressing the mutated subunit confirmed this prediction and showed an associated reduced glutamate affinity. Moreover, GluN2B(P553T)-expressing primary murine hippocampal neurons showed decreased spine density, concomitant with reduced NMDA-evoked currents and impaired NMDAR-dependent insertion of the AMPA receptor subunit GluA1 at stimulated synapses. Furthermore, the naturally occurring coagonist D-serine restored function to GluN2B(P553T)-containing NMDAR5. L-Serine dietary supplementation of the patient was hence initiated, resulting in the increased abundance of D-serine in the plasma and brain. The patient has shown notable improvements in motor and cognitive performance and communication after 11 and 17 months of L-serine dietary supplementation. Our data suggest that L-serine supplementation might ameliorate GRIN2B-related severe encephalopathy and other neurological conditions caused by glutamatergic signaling deficiency.

Filiaciones:
Soto, D:
 Univ Barcelona, Inst Neurosci, E-08036 Barcelona, Spain

 Univ Barcelona, Dept Biomed, E-08036 Barcelona, Spain

 August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona 08036, Spain

Olivella, M:
 Cent Univ Catalonia, Univ Vic, Bioinfomat & Med Stat Grp, Vic 08500, Spain

Grau, C:
 Univ Barcelona, Unit Neuropharmacol & Pain, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain

Armstrong, J:
 Hosp St Joan Deu, Genet & Mol Med Serv, Barcelona 08950, Spain

 CIBERER, Barcelona 08950, Spain

Alcon, C:
 Univ Barcelona, Inst Neurosci, E-08036 Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, E-08036 Barcelona, Spain

Gasull, X:
 Univ Barcelona, Inst Neurosci, E-08036 Barcelona, Spain

 Univ Barcelona, Dept Biomed, E-08036 Barcelona, Spain

 August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona 08036, Spain

Santos-Gomez, A:
 Univ Barcelona, Unit Neuropharmacol & Pain, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain

Locubiche, S:
 Univ Barcelona, Unit Neuropharmacol & Pain, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain

de Salazar, MG:
 Univ Barcelona, Unit Neuropharmacol & Pain, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain

Garcia-Diaz, R:
 Univ Barcelona, Inst Neurosci, E-08036 Barcelona, Spain

 Univ Barcelona, Dept Biomed, E-08036 Barcelona, Spain

 August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona 08036, Spain

 Univ Santiago de Cali, Grp Invest Quim & Biotecnol QUIBIO, Santiago De Cali 760035, Colombia

Gratacos-Batlle, E:
 Univ Barcelona, Inst Neurosci, E-08036 Barcelona, Spain

 Univ Barcelona, Dept Biomed, E-08036 Barcelona, Spain

 August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona 08036, Spain

Ramos-Vicente, D:
 Biomed Res Inst St Pau IIB St Pau, Mol Physiol Synapse Lab, Barcelona 08026, Spain

 Autonomous Univ Barcelona, Bellaterra 08193, Spain

Chu-Van, E:
 Univ Paris Saclay, MetaboHUB, SPI, Lab Etud Metab Medicaments,CEA,INRA, F-91191 Gif Sur Yvette, France

Colsch, B:
 Univ Paris Saclay, MetaboHUB, SPI, Lab Etud Metab Medicaments,CEA,INRA, F-91191 Gif Sur Yvette, France

Fernandez-Duenas, V:
 Univ Barcelona, Unit Neuropharmacol & Pain, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain

Ciruela, F:
 Univ Barcelona, Unit Neuropharmacol & Pain, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain

Bayes, A:
 Biomed Res Inst St Pau IIB St Pau, Mol Physiol Synapse Lab, Barcelona 08026, Spain

 Autonomous Univ Barcelona, Bellaterra 08193, Spain

Sindreu, C:
 Univ Barcelona, Inst Neurosci, E-08036 Barcelona, Spain

 Univ Barcelona, Dept Clin Fdn, E-08036 Barcelona, Spain

Lopez-Sala, A:
 CIBERER, Barcelona 08950, Spain

 Hosp St Joan Deu, Dept Neurol, Neurometab Unit, Barcelona 08950, Spain

Garcia-Cazorla, A:
 Hosp St Joan Deu, Genet & Mol Med Serv, Barcelona 08950, Spain

 CIBERER, Barcelona 08950, Spain

 Hosp St Joan Deu, Dept Neurol, Neurometab Unit, Barcelona 08950, Spain

Altafaj, X:
 Univ Barcelona, Unit Neuropharmacol & Pain, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Spain
ISSN: 19450877





Science Signaling
Editorial
AMER ASSOC ADVANCEMENT SCIENCE, 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 12 Número: 586
Páginas:
WOS Id: 000471904600002
ID de PubMed: 31213567
imagen Bronze

MÉTRICAS